Press release - intarcia announces FDA filing acceptance of new drug application (NDA) for ITCA 650 for the treatment of type 2 diabetes
For this reason, ensuring that your glutathione levels are optimal is very important if you have Hashimotos thyroiditis
Scientists are looking for ways to manage the high cost of these medications while ensuring appropriate use
Wegovy is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities
Warning: Do not use if pregnant or breastfeeding, elderly, under the age of 18, or if the safety seal is broken
Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)